In a rare steak of bipartisanism after the midterm elections, the President and major congressional leaders have all acknowledge that legislative action on rising drug prices is an area where they could all successfully work together. President Trump has recently put forth a radical Radical proposal to lower drug prices for Medicare. And Rep. Peter Welch, a Vermont Democrat, a vocal proponent of legislation to control drug prices has taken a leadership role on this topic. Senate Majority Leader Mitch McConnell (R-Ky.) also acknowledged that drug prices is an area of opportunity for cooperation across party lines. It is sure to be a battle with the pharmaceutical industry. But perhaps all parties could understand the people’s need for stability and predictability in medication prices while still fostering innovation.